Food intake is tightly regulated by a group of neurons present in the mediobasal hypothalamus which activate satiety by releasing Pomc-encoded melanocortins. Although the relevance of hypothalamic POMC neurons in the regulation of energy balance and body weight is well appreciated, little is known about the transcription factors that establish their cellular fate, terminal differentiation and phenotypic maintenance. Here, we report that the transcription factor Nkx2.1 activates hypothalamic Pomc expression from early development to adulthood by binding to conserved canonical NKX motifs present in the neuronal Pomc enhancers nPE1 and nPE2. Transgenic and mutant mouse studies showed that the NKX motifs present in nPE1 and nPE2 are essential for their transcriptional enhancer activity. Early inactivation of Nkx2.1 in the ventral hypothalamus prevented the onset of Pomc expression and selective Nkx2.1 ablation from POMC neurons impaired Pomc expression and increased body weight and adiposity. These results demonstrate that NKX2.1 is critical in the early establishment of arcuate melanocortin neurons and the regulation of Pomc expression and body weight in adulthood. Nkx2.1 sets melanocortin neuron identity -Orquera &Tavella et al., 2018 3
Although ISL1 is necessary for Pomc expression, it is clearly not sufficient. Isl1 is expressed not only in a much broader hypothalamic territory than Pomc, but also in other neuronal types where Pomc is never found (22) (23) (24) . Thus, other TFs are likely to participate in the arcuate-specific expression of Pomc. Here, we combined molecular, cellular, genetic and functional studies we show to demonstrate that the homeodomain TF NKX2.1 plays a crucial role in arcuate Pomc expression from early development to adulthood by interacting with motifs present in nPE1 and nPE2. Therefore, NKX2.1 defines the identity of hypothalamic melanocortin neurons and is necessary to maintain sufficient levels of hypothalamic Pomc mRNA in adult mice to assure normal body weight regulation.
Results

NKX2.1 is a candidate TF for the regulation of hypothalamic Pomc expression
Within the neuronal Pomc enhancer nPE1 we detected a canonical binding motif for a TF of the NKX subfamily which is highly conserved in all mammalian orders (Fig. 1, left and Fig. S1 ) while two conserved canonical NKX binding sites are present in nPE2 (Fig. 1, right and Fig. S2 ). Among all NKX family members, NKX2.1 emerged as the most likely candidate to regulate hypothalamic Pomc expression because it is present in the early developing ventral hypothalamus portion that gives rise to the arcuate nucleus (25-28), and continues to be expressed in this nucleus during postnatal life (29) . A necessary condition to support NKX2.1 as a transactivator of hypothalamic Pomc is that both genes coexpress within the same neurons. We followed the developmental pattern of Nkx2.1 expression in the ventromedial hypothalamus in sagittal sections of Pomc-EGFP mice, a validated transgenic line that coexpresses EGFP and Pomc along the entire spatiotemporal domain and that is useful to maximize the identification of POMC neurons ( Fig. S3) (3, 21) . At the onset of Pomc expression in the mouse hypothalamus (E10.5) (30), all incipient Pomc-EGFP neurons also express Nkx2.1 (Fig. 2 a,b ,c). The expression territory of Nkx2.1 is much broader than that of Pomc extending beyond the limits of the future arcuate nucleus. Expression of Nkx2.1 in all POMC neurons is also evident at E12.5, when neurogenesis of POMC neurons is highest ( Fig. 2 d ,e,f). In the adult arcuate nucleus, most Pomc-EGFP positive-neurons are immunopositive for NKX2.1 (Fig. 2 g,h,i) but, as in earlier stages, the total number of NKX2.1 immunopositive neurons is greater than that of POMC neurons. Together, these results show that POMC neurons express Nxk2.1 in the ventromedial hypothalamus during development and adulthood.
NKX2.1 specifically binds in vitro and in vivo to DNA elements present in nPE1 and nPE2
We then examined the in vitro binding properties of NKX2.1 in electrophoretic mobility shift assays (EMSA) using a bacterially expressed mouse Nkx2.1 clone. We found that 30-bp DNA probes encompassing canonical NKX motifs present in nPE1 or nPE2 were shifted when incubated with NKX2.1 bacterial extracts (Fig. 3a) . To test whether NKX2.1 interacts with nPE sequences in vivo we performed a chromatin immunoprecipitation (ChIP) assay using chromatin harvested from adult mouse hypothalami. An anti-NKX2.1 antibody pulled down nPE1 and nPE2 sequences that were amplified by PCR whereas a control IgG antibody failed to immunoprecipitate either nPE sequence (Fig. 3b,c) .
Functional analysis of NKX binding sites present in the neuronal Pomc enhancers nPE1 and nPE2
In previous studies we demonstrated that the sole presence of nPE1 or nPE2 in transgenic constructs is sufficient to drive reporter gene expression to arcuate POMC neurons (17, 19) . To determine the functional relevance of the two NKX binding motifs present in nPE2 ( Fig. 1b) , we tested whether a mutant version carrying transition mutations in these two binding sites is able to drive EGFP expression to the arcuate nucleus of transgenic mice ( Fig. 4a ). Both transgenes carried the mouse Pomc proximal promoter known to drive reporter gene expression exclusively to POMC pituitary cells which allows us to discard transgenic mice carrying silent integrations (18, 31). As expected from previous studies (16), we found that transgene nPE2Pomc-EGFP drove expression to arcuate hypothalamic neurons in three different pedigrees To test the importance of the unique NKX binding site present in nPE1, we took a different genetic approach using CRISPR/Cas9 technology to selectively delete the motif from nPE1 by targeted mutagenesis of Pomc alleles already lacking nPE2 (20). We microinjected Pomc +/ΔnPE2 zygotes with a sgRNA directed to the unique NKX site present in nPE1 and obtained nPE1(ΔNKX) mutant alleles that, in addition, lack nPE2 (Pomc nPE1(ΔNKX).ΔnPE2 ; Fig. 4h ). Pomc ΔnPE2/ΔnPE2 E12.5 embryos showed reduced Pomc expression levels compared to Pomc +/+ controls, in agreement with our previous findings ( Fig. 4i, . 4m ) and are significantly heavier (34.9 +/-0.4 g) than their wild type littermates (30.6 +/-0.5 g; Fig. 4n ). These results reveal that the NKX motif present in nPE1 is a functionally critical component of this enhancer. Altogether, our transgenic and mutant studies demonstrate that the neuronal Pomc enhancers nPE1 and nPE2 depend on their NKX binding sites to fully drive endogenous or reporter gene expression in hypothalamic neurons and suggest that NKX2.1 is critically involved in neuronal Pomc expression.
NKX2.1 is critical for the early establishment of hypothalamic melanocortin neuron identity
To investigate whether NKX2.1 participates in the establishment of the hypothalamic POMC lineage and/or in the developmental expression of Pomc we used a conditional mutant mouse strain that allowed Nkx2.1 ablation at different developmental time points. In Nkx2.1 loxP/loxP mice, the homeodomain-encoding exon 2 is flanked by two loxP sites so that null alleles are generated upon Cre recombinase activation (32). By crossing Nkx2.1 loxP/loxP conditional mutants with mice harbouring a transgene that ubiquitously expresses a tamoxifen-inducible Cre recombinase (CAAG-CreERT) (33) we obtained inducible Nkx2.1 loxP/loxP .CAAG-CreER mice, that for simplicity we named IndNkx2.1KO. Pregnant Nkx2.1 loxP/loxP dams mated with IndNkx2.1KO males received a single tamoxifen (TAM) injection at different developmental time points (E8.5, E9.5 and E10.5) and IndNkx2.1KO and Nkx2.1 loxP/loxP littermates were collected at E12.5, with the latter being used as controls. IndNkx2.1KO embryos receiving TAM at E8.5 (Nkx2.1KO@E8.5) showed complete absence of NKX2.1 when evaluated in E12.5 sagittal sections ( Fig. 5 a,b ), demonstrating that this dose of TAM induced efficient recombination of the conditional Nkx2.1 loxP alleles. Nkx2.1KO@E8.5 embryos showed a thinning of the ventral neuroepithelium at the level of the future hypothalamus and lack of infundibulum, as found in In a previous study we showed that the onset of hypothalamic Pomc expression at E10.5 depends on the earlier expression of the TF ISL1, that starts at E10.0 in maturing postmitotic neurons of the future arcuate nucleus (21). Given that the onset of Nkx2.1 expression in the developing hypothalamus precedes that of Isl1, we tested the hypothesis that NKX2.1 could also activate Pomc expression via ISL1 alternatively to its direct effect acting on the NKX binding sites present in nPE1 and nPE2. We found, however, normal ISL1 immunoreactivity in ventromedial hypothalamic neurons of Nkx2.1KO@E9.5 embryos ( Fig. 5i These results, together with those shown in the sections above, support the idea that NKX2.1 activates Pomc expression directly.
Nkx2.1 expression in ISL1 neurons is critical for hypothalamic Pomc expression
To limit Nkx2.1 ablation to the lineage leading to arcuate POMC neurons we decided to inactivate Nkx2.1 alleles specifically in neurons expressing Isl1. We found that the pattern of Isl1 expression within the presumptive arcuate nucleus at E10.5 overlaps with that of Nkx2.1 
Discussion
In this study we combined molecular, genetic, cellular, and functional approaches to demonstrate that the homeodomain transcription factor NKX2.1 is necessary to activate and maintain arcuate-specific Pomc expression from early development to adulthood. Therefore, Further genetic studies showed that this conserved intronic sequence is a tissue-specific enhancer that controls not FTO but a distant gene coding for the TF Irx3 (48). Another exceptional single locus is POMC, since a number of genome-wide studies have found highly significant linkage scores between obesity-related traits and a genomic segment in chromosome 2 near POMC (49, 50)(51). Although polymorphisms in POMC coding sequences do not appear to account for these associations (52), it is likely that mutations in noncoding regulatory elements may alter POMC transcript levels and modify the relative amount of central melanocortins.
Our finding that NKX2.1 binds to canonical NKX binding motifs present in nPE1 and nPE2 adds to the adaptive partial redundancy of arcuate Pomc expression that relies on the presence of these two enhancers for full transcriptional activity (20). During mammalian evolution, nPE1 and nPE2 were independently exapted (co-opted) from different types of retroposons (19). This long lasting evolutionary process in which two different retroposon-derived sequences became functional neuronal Pomc enhancers involved the independent acquisition of NKX binding sites in each of them, as we previously found for ISL1 binding sites (21). Because the individual ablation of Nkx2.1 or Isl1 from early developmental stages prevents the onset of hypothalamic Pomc expression we conclude that the combinatorial presence of NKX2.1 and ISL1 is necessary to determine the identity of arcuate melanocortin neurons. In fact, in this study we show that Pomc is expressed in NKX2.1+, ISL1+ neurons. However, since the expression territories of these two TFs in the arcuate nucleus is much broader than that of Pomc, it is clear that these two TFs are not sufficient for arcuate-specific Pomc expression and that at least another TF, yet to be discovered, is necessary to dictate the final identity of POMC neurons. The two NKX-binding sites present in nPE2 are shown within blue squares. Table S1 .
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Materials and Methods
Breeding of Mice
Transgene and Transgenic mice production.
Transgene nPE2Pomc-EGFP was previously reported (3, 4) . Transgene nPE2(NKX*)Pomc-EGFP is identical except for carrying two transversion mutations in each of the two NKX binding sites present in nPE2 (TCAAG→TCCCG and TCAAT→TCCCT). This transgene was generated using a standard megaprimer PCR protocol as previously described (5) but with the primers described in Table S1 . Introduction of mutations was confirmed by sequencing. Transgenes were digested with NotI and SalI restriction enzymes and the fragment of interest was separated and Table S1 and PCR products subcloned in pGEM.T Easy Vector for sequencing. A strain carrying a 34 bp deletion (chr12:3,942,178-3,942,211) in nPE1 in a ΔnPE2 allele was selected and maintained in a C57BL6/J background and F2 mice were analyzed.
Tamoxifen injections
Tamoxifen (T5648, Sigma) was dissolved in sesame oil (S3547, Sigma) at 15 mg/mL by sonication. 1 ml aliquots were stored at -20ºC and thawed for 10 minutes at 37ºC before injection. Pregnant females were injected intraperitoneally with a dose of 133 mg/kg.
Tissue collection and embedding
Pregnant mice at 10.5-15.5 days post coitum (dpc, the day of detection of vaginal plug was considered dpc 0.5) were dislocated and embryos were collected and washed in cold RNAsefree PBS. Fixation was performed with 4% PFA-PBS at 4°C, for a period of time dependent on developmental stage. 10.5, 11.5 and 12.5 dpc embryos were fixed for 2hs, 15.5 dpc embryos´ heads were dissected and fixed for 4hs and newborns´ heads were fixed overnight. Samples were then washed in cold PBS and cryoprotected with 10% sucrose-PBS overnight. Tails or
Pomc mRNA Quantification by RT-qPCR
Whole mouse adult hypothalami or embryo heads were dissected, collected in ice-cold TriPure Isolation Reagent (Sigma, Cat. Nr. 11667165001) and stored at -80°C until RNA extraction, which was performed following manufacturer's instructions. RNA integrity was assessed by gel electrophoresis; clear 28S and 18s rRNA were observed in an approximate 2:1 ratio.
Quantification was performed using a Nanodrop and 260/280 and 260/230 ratios were checked to assess purity. 1 μg of RNA was DNAse I (Ambion Cat. No.: AM2222) treated and used for firststrand cDNA synthesis, using High Capacity Reverse Transcription Kit with random primers (Applied Biosystems, Cat Nr. 4368814). Primers were designed with Primer 3 program. Pomc mRNA was quantified using primers spanning exons 2 and 3 relative to internal control genes β2-microglobulin (B2m) and β-actin (Actb). Primer sequences are listed in Table S1 . Samples 
Electrophoretic mobility shift assay (EMSA)
A mouse Nkx2.1 cDNA clone (ATCC, No.: 10698306) was subcloned into the expression vector pGEX 4T3 using NcoI and EcoRI restriction enzymes and transformed into Escherichia coli BL21 strain. Protocols for obtaining bacterial extracts, radioactive labeling of DNA probes and preparation of EMSA reactions were previously described (6) . After electrophoresis, gels were dried and exposed to X-ray film (Kodak BioMax MS) or Storage Phosphor Screen that was subsequently scanned in a STORM 860 Phospho Imager using ImageQuant5.2 software (Amersham Biosciences). Probe sequences are shown in Table S1 .
Chromatin Immunoprecipitation (ChIP)
Hypothalami from 5 adult mice were collected and fixed in 1% PFA-PBS for 20 minutes at 4°C. Table 1 ).
Samples
Statistics
All data presented are the mean ± SEM and were analyzed using GraphPad Prism by repeated measures ANOVA or Student's t test unless otherwise stated. In the case of RT-qPCR performed in embryos, variances were unequal as determined by Bartlett´s test and dependent on the mean. In order to perform ANOVA, variance was modelled using VarPower function of "nmle" package in R Studio (7) . Post hoc pairwise comparisons between groups were performed by Tukey test. P values less than 0.05 were considered significant. Table S1 . Primer sequences used to detect different alleles and mutations and probes for EMSA studies
